Chemoinformaics analysis of 1,7-diphenyl-5-hydroxy-6-hepten-3-one
| Molecular Weight | 280.367 | nRot | 7 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 14 |
| Exact Molecular Weight | 280.146 | nRing | 2 |
| Solubility: LogS | -3.389 | nHRing | 0 |
| Solubility: LogP | 2.872 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 46.6699 |
| nHD | 1 | BPOL | 20.9321 |
| QED | 0.84 |
| Synth | 2.429 |
| Natural Product Likeliness | 0.994 |
| NR-PPAR-gamma | 0.91 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.713 |
| Pgp-sub | 0.864 |
| HIA | 0.067 |
| CACO-2 | -4.754 |
| MDCK | 0.0000184 |
| BBB | 0.717 |
| PPB | 0.966164 |
| VDSS | 0.992 |
| FU | 0.0084393 |
| CYP1A2-inh | 0.579 |
| CYP1A2-sub | 0.111 |
| CYP2c19-inh | 0.773 |
| CYP2c19-sub | 0.103 |
| CYP2c9-inh | 0.702 |
| CYP2c9-sub | 0.421 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.54 |
| CYP3a4-inh | 0.038 |
| CYP3a4-sub | 0.448 |
| CL | 12.031 |
| T12 | 0.867 |
| hERG | 0.176 |
| Ames | 0.137 |
| ROA | 0.028 |
| SkinSen | 0.936 |
| Carcinogencity | 0.088 |
| EI | 0.692 |
| Respiratory | 0.207 |
| NR-Aromatase | 0.044 |
| Antiviral | No |
| Prediction | 0.625648 |